| Identification | Back Directory | [Name]
Matuzumab | [CAS]
339186-68-4 | [Synonyms]
Kgaa
Emd 72000
Emd-72000
Matuzumab
Merck kgaa
Matuzumab - 10 mg/ml
Research Grade Matuzumab(DHB86906) |
| Hazard Information | Back Directory | [Uses]
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth[1]. | [References]
[1] Joan H Schiller. Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000). Cancer Invest. 2008 Feb;26(1):81-95. DOI:10.1080/07357900701511847 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
|